|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010583,
umls-concept:C0018799,
umls-concept:C0024299,
umls-concept:C0030705,
umls-concept:C0032952,
umls-concept:C0042679,
umls-concept:C0205195,
umls-concept:C0205420,
umls-concept:C0282564,
umls-concept:C0393022,
umls-concept:C0717726
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-12-10
|
|
pubmed:abstractText |
To assess the efficacy and safety of the combination of non-pegylated liposome-encapsulated doxorubicin (Myocet(R)) with cyclophosphamide, vincristine, prednisone and rituximab (R-COMP) in patients with aggressive non-Hodgkin's B-cell lymphomas.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0278-0232
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
198-203
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17654614-Aged,
pubmed-meshheading:17654614-Anthracyclines,
pubmed-meshheading:17654614-Antibodies, Monoclonal,
pubmed-meshheading:17654614-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:17654614-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17654614-Cyclophosphamide,
pubmed-meshheading:17654614-Doxorubicin,
pubmed-meshheading:17654614-Female,
pubmed-meshheading:17654614-Heart Diseases,
pubmed-meshheading:17654614-Humans,
pubmed-meshheading:17654614-Lymphoma,
pubmed-meshheading:17654614-Male,
pubmed-meshheading:17654614-Middle Aged,
pubmed-meshheading:17654614-Prednisone,
pubmed-meshheading:17654614-Premedication,
pubmed-meshheading:17654614-Stroke Volume,
pubmed-meshheading:17654614-Treatment Outcome,
pubmed-meshheading:17654614-Vincristine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines.
|
|
pubmed:affiliation |
Department of Hematology, Careggi Hospital and University of Florence, Italy. l.rigacci@dac.unifi.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
